BR9707002A - Derivados benzoil guanidina processos para sua preparação e seu uso na preparação de composições farmacêuticas - Google Patents

Derivados benzoil guanidina processos para sua preparação e seu uso na preparação de composições farmacêuticas

Info

Publication number: BR9707002A
Authority: BR; Brazil
Prior art keywords: preparation; pharmaceutical compositions; guanidine derivatives; benzoyl guanidine; derivatives processes
Prior art date: 1996-01-16

Application number

BR9707002A

Other languages

English (en)

Inventor

Erich Buerger

Christian Eickmeier

Otto Roos

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-16

Filing date

1997-01-16

Publication date

1999-07-20

1997-01-16 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

1999-07-20 Publication of BR9707002A publication Critical patent/BR9707002A/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Furan Compounds (AREA)
Pyrrole Compounds (AREA)

BR9707002A 1996-01-16 1997-01-16 Derivados benzoil guanidina processos para sua preparação e seu uso na preparação de composições farmacêuticas BR9707002A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19601303A DE19601303A1 (de)	1996-01-16	1996-01-16	Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln
PCT/EP1997/000177 WO1997026253A1 (de)	1996-01-16	1997-01-16	Neuartige benzoylguanidin-derivate, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von arzneimitteln

Publications (1)

Publication Number	Publication Date
BR9707002A true BR9707002A (pt)	1999-07-20

Family

ID=7782846

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9707002A BR9707002A (pt)	1996-01-16	1997-01-16	Derivados benzoil guanidina processos para sua preparação e seu uso na preparação de composições farmacêuticas

Country Status (26)

Country	Link
US (1)	US6114335A (pt)
EP (1)	EP0882031A1 (pt)
JP (1)	JP2000503309A (pt)
KR (1)	KR19990077304A (pt)
CN (1)	CN1072663C (pt)
AR (1)	AR005468A1 (pt)
AU (1)	AU722619B2 (pt)
BG (1)	BG102623A (pt)
BR (1)	BR9707002A (pt)
CA (1)	CA2240075A1 (pt)
CO (1)	CO4761058A1 (pt)
CZ (1)	CZ225398A3 (pt)
DE (1)	DE19601303A1 (pt)
EE (1)	EE9800200A (pt)
HU (1)	HUP9900584A3 (pt)
IL (1)	IL124779A0 (pt)
NO (1)	NO311517B1 (pt)
NZ (1)	NZ326347A (pt)
PL (1)	PL327854A1 (pt)
RU (1)	RU2181720C2 (pt)
SK (1)	SK282751B6 (pt)
TR (1)	TR199801328T2 (pt)
TW (1)	TW426673B (pt)
UA (1)	UA48214C2 (pt)
WO (1)	WO1997026253A1 (pt)
ZA (1)	ZA97277B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6323207B1 (en) *	1998-09-22	2001-11-27	Boehringer Ingelheim Pharma Kg	Benzoylguanidine derivatives
DE19843489B4 (de) *	1998-09-22	2006-12-21	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung
JP2000219674A (ja) *	1999-01-29	2000-08-08	Daiichi Radioisotope Labs Ltd	新規アラルキルグアニジン化合物
PT1353672E (pt) *	2000-11-30	2008-01-11	Childrens Medical Center	Síntese da 4-amino talidomida enantiómeros
IL147696A0 (en) *	2001-01-25	2002-08-14	Pfizer Prod Inc	Combination therapy
US6730678B2 (en) *	2001-02-15	2004-05-04	Boehringer Ingelheim Pharma Kg	Benzoylguanidine salt and hydrates thereof
DE10106970A1 (de) *	2001-02-15	2002-08-29	Boehringer Ingelheim Pharma	Neues Benzoylguanidinsalz
DE10204989A1 (de) *	2002-02-07	2003-08-21	Aventis Pharma Gmbh	Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US7323479B2 (en) *	2002-05-17	2008-01-29	Celgene Corporation	Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
UA83504C2 (en)	2003-09-04	2008-07-25	Селджин Корпорейшн	Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
MX2007002521A (es) *	2004-09-03	2007-05-09	Celgene Corp	Procesos para la preparacion de 2-(2,6-dioxopiperidin-3-il)-1- oxoisoindolinas sustituidas.
SI2380887T1 (sl)	2005-06-30	2013-12-31	Celgene Corporation	Postopki priprave spojin 4-amino-2-/2,6-dioksopiperidin-3-il)izoindolin -1,3-diona
WO2007062222A2 (en) *	2005-11-22	2007-05-31	University Of South Florida	Inhibition of cell proliferation
US20080064876A1 (en) *	2006-05-16	2008-03-13	Muller George W	Process for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
JP2011527677A (ja) *	2008-07-08	2011-11-04	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｎｈｅ−１阻害剤として有用なピロリジニル及びピペリジニル化合物
WO2010025448A2 (en) *	2008-08-29	2010-03-04	University Of South Florida	Inhibition of cell proliferation
WO2013126394A1 (en)	2012-02-21	2013-08-29	Celgene Corporation	Solid forms of 3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
EP2815749A1 (en)	2013-06-20	2014-12-24	IP Gesellschaft für Management mbH	Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0589336T3 (da) *	1992-09-22	1997-06-16	Hoechst Ag	Benzylguanidiner, fremgangsmåde til deres fremstilling samt deres anvendelse som antiarytmetika
ES2129485T3 (es) *	1992-12-02	1999-06-16	Hoechst Ag	Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
TW250477B (pt) *	1992-12-15	1995-07-01	Hoechst Ag
DE4337611A1 (de) *	1993-11-04	1995-05-11	Boehringer Ingelheim Kg	Neue Benzoylguanidine, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE4404183A1 (de) *	1994-02-10	1995-08-17	Merck Patent Gmbh	4-Amino-1-piperidylbenzoylguanidine
DE4430861A1 (de) *	1994-08-31	1996-03-07	Merck Patent Gmbh	Heterocyclyl-benzoylguanidine

1996
- 1996-01-16 DE DE19601303A patent/DE19601303A1/de not_active Withdrawn
1997
- 1997-01-14 ZA ZA97277A patent/ZA97277B/xx unknown
- 1997-01-15 CO CO97001473A patent/CO4761058A1/es unknown
- 1997-01-15 TW TW086100385A patent/TW426673B/zh not_active IP Right Cessation
- 1997-01-15 AR ARP970100146A patent/AR005468A1/es not_active Application Discontinuation
- 1997-01-16 EP EP97901043A patent/EP0882031A1/de not_active Withdrawn
- 1997-01-16 SK SK957-98A patent/SK282751B6/sk unknown
- 1997-01-16 RU RU98115533/04A patent/RU2181720C2/ru not_active IP Right Cessation
- 1997-01-16 EE EE9800200A patent/EE9800200A/xx unknown
- 1997-01-16 TR TR1998/01328T patent/TR199801328T2/xx unknown
- 1997-01-16 CN CN97191727A patent/CN1072663C/zh not_active Expired - Fee Related
- 1997-01-16 CZ CZ982253A patent/CZ225398A3/cs unknown
- 1997-01-16 HU HU9900584A patent/HUP9900584A3/hu unknown
- 1997-01-16 CA CA002240075A patent/CA2240075A1/en not_active Abandoned
- 1997-01-16 UA UA98084428A patent/UA48214C2/uk unknown
- 1997-01-16 JP JP9525687A patent/JP2000503309A/ja active Pending
- 1997-01-16 IL IL12477997A patent/IL124779A0/xx unknown
- 1997-01-16 KR KR1019980705450A patent/KR19990077304A/ko not_active Ceased
- 1997-01-16 AU AU14429/97A patent/AU722619B2/en not_active Ceased
- 1997-01-16 NZ NZ326347A patent/NZ326347A/en unknown
- 1997-01-16 BR BR9707002A patent/BR9707002A/pt not_active IP Right Cessation
- 1997-01-16 PL PL97327854A patent/PL327854A1/xx unknown
- 1997-01-16 US US09/101,792 patent/US6114335A/en not_active Expired - Fee Related
- 1997-01-16 WO PCT/EP1997/000177 patent/WO1997026253A1/de not_active Ceased
1998
- 1998-07-10 BG BG102623A patent/BG102623A/xx unknown
- 1998-07-15 NO NO19983261A patent/NO311517B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
BG102623A (bg)	1999-03-31
JP2000503309A (ja)	2000-03-21
HK1016981A1 (en)	1999-11-12
WO1997026253A1 (de)	1997-07-24
HUP9900584A3 (en)	2001-01-29
UA48214C2 (uk)	2002-08-15
AR005468A1 (es)	1999-06-23
NO983261D0 (no)	1998-07-15
NO983261L (no)	1998-07-15
SK95798A3 (en)	1999-01-11
PL327854A1 (en)	1999-01-04
TR199801328T2 (xx)	1998-10-21
US6114335A (en)	2000-09-05
CA2240075A1 (en)	1997-07-24
HUP9900584A2 (hu)	1999-07-28
NO311517B1 (no)	2001-12-03
RU2181720C2 (ru)	2002-04-27
SK282751B6 (sk)	2002-12-03
CO4761058A1 (es)	1999-04-27
KR19990077304A (ko)	1999-10-25
NZ326347A (en)	2001-03-30
CZ225398A3 (cs)	1998-12-16
AU1442997A (en)	1997-08-11
IL124779A0 (en)	1999-01-26
CN1208409A (zh)	1999-02-17
DE19601303A1 (de)	1997-07-17
EP0882031A1 (de)	1998-12-09
TW426673B (en)	2001-03-21
CN1072663C (zh)	2001-10-10
ZA97277B (en)	1997-07-16
EE9800200A (et)	1998-12-15
AU722619B2 (en)	2000-08-10

Publication	Publication Date	Title
BR9707002A (pt)	1999-07-20	Derivados benzoil guanidina processos para sua preparação e seu uso na preparação de composições farmacêuticas
BR9005261A (pt)	1991-09-17	Formulacao para revestimentos de liberacao contida e seu uso
BR9711166A (pt)	1999-08-17	PrÄtese de enxerto materiais para sua prepara-Æo e m-todos para seu uso
BR9609951A (pt)	1999-02-02	Novas composições farmacêuticas e seu uso
BR9506561A (pt)	1997-10-28	Co-grânulo homogêneo composição detergente tablete de detergente processos para sua preparação e uso dos mesmos
PT100779A (pt)	1993-09-30	Acidos amidazolil-alcenoico, composicoes farmaceuticas que os contem e seu uso
BR9406566A (pt)	1996-02-06	Composição farmacêutica uso de progesterona e/ou 17 - - estradiol e processo para a fabricação de uma preparação farmacêutica
FI954143L (fi)	1995-10-19	Kiinteitä lipidihiukkasia, bioaktiivisten aineiden hiukkasia, menetelmiä niiden valmistamiseksi ja niiden käyttö
MX17752A (es)	1993-12-01	Formulaciones farmaceuticas y procedimiento para prepararlas
BR9307226A (pt)	1999-05-11	Novos derivados de pirazol substituidos processos para sua preparação e seu uso como herbicida
BR9707501A (pt)	1999-07-27	Composto composição farmacêutica e uso do composto
BR9505107A (pt)	1997-09-09	Composto composiçao farmacêutica processo para a preparaçao de um composto e seu uso
IT1240605B (it)	1993-12-17	Composizione farmaceutica solida e procedimento per la sua preparazione
BR9602915A (pt)	1998-04-22	Medicamentos uso e formulação farmacêutica
BR9707808A (pt)	1999-07-27	Composto composição farmacêutica e uso do composto
BR9611949A (pt)	1999-03-30	Novos derivados de fenilamidina processos para preparação dos mesmos e seu uso como composições farmacêuticas
AR011441A1 (es)	2000-08-16	DERIVADOS ÉSTERES Y AMIDAS DE FENIL XANTINA ,PROCESOS PARA SU PREPARACIoN , FORMULACIONES FARMACÉUTICAS Y SU USO EN MEDICINA
FR2609391B1 (fr)	1991-02-15	Preparations pharmaceutiques sous forme de suppositoires bioadhesifs
PT1025100E (pt)	2002-07-31	Derivados de tetra-hidropiridopirimidona substituidos na posicao 3 sua preparacao e sua utilizacao
BR9612413A (pt)	1999-07-13	Composto uso do mesmo e composição farmacêutica
MX9205164A (es)	1993-03-01	Nuevos derivados (beta)-carbolino para su preparacion y utilizacion en medicamentos.
DK0397175T3 (da)	1994-02-14	Substituerede pyrrolizinforbindelser og deres anvendelse inden for farmacien
DE69024843D1 (de)	1996-02-29	Rhodanin-Derivate und pharmazeutische Zusammensetzungen
KR900012897A (ko)	1990-09-03	구아니딘 유도체 및 이를 함유하는 약제학적 조성물
MX9100952A (es)	1992-05-04	Composiciones de tereftalato de polietileno y metodos para su uso

Legal Events

Date	Code	Title	Description
2006-03-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 8A E 9A ANUIDADES.
2011-12-06	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1834 DE 01/03/2006.